KRYSTAL WEBER: Open Payments
NPI 1003682816 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 23 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $867 · 2025 $661
Food & beverage: $448Education: $213
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 14 | $402 |
| E.R. Squibb & Sons, L.L.C. | 3 | $143 |
| Alkermes, Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: UZEDY, COBENFY, ARISTADA, Auvelity, AUSTEDO XR, CAPLYTA, INVEGA SUSTENNA.
Industry payments across WA — which companies pay providers there.
